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Background/Purpose: Magnesium deﬁciency has been a common, but easily ignored, electrolyte abnor-
mality. Studies on magnesium deﬁciency are lacking in India, especially in a rural setting. Here, we have
correlated serum magnesium levels with outcomes in elderly patients admitted to the medical intensive
care unit with respect to the length of intensive care unit stay, need for mechanical ventilatory support
and its duration, and outcome (discharge/death).
Methods: A prospective, observational study was conducted in patients aged 60 years and older, who had
been admitted to the intensive care unit of the medicine department for over a year. The chi-square test
was applied to correlate hypomagnesemia with the outcome.
Results: In our study, 59.30% of the elderly patients had hypomagnesemia. Compared with patients with
a normal magnesium level, hypomagnesemic patients had no correlation with the duration of medical
intensive care unit stay (5.57± 6.10 days vs. 5.61± 5.55 days), but the need for mechanical ventilation
(57.84% vs. 45.71%), rate of discharge from the intensive care unit or cure (60.28% vs. 71.42% ), rate of
death (39.21% vs. 28.57%), and mean duration of ventilation (3.07± 5.05 days vs. 2.15± 3.46 days) were
higher. However, no signiﬁcant statistical difference was found between these groups.
Conclusion: Hypomagnesemia was associated with a slightly higher mortality rate. Requirement and
duration of ventilatory support were also higher, although not statistically signiﬁcant. Hypomagnesemia
was not found to have any impact on the duration of medical intensive care unit stay. Monitoring of
serum magnesium levels may have prognostic and perhaps therapeutic implications in the elderly.
Copyright © 2016, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Serum magnesium is currently receiving more attention from
the medical community than in the past because of evidence that
its deﬁciency contributes to a number of abnormal perturbations as
it inﬂuences over 300 enzyme systems, including NaeKeATPase-
mediated transport, and is essential for calcium homeostasis, nerve
conduction, skeletal muscle activity, and maintenance of calcium
and potassium homeostasis. This is especially apparent in geriatric
patients because of their low magnesium intake, diminished in-
testinal absorption, and increased urinary output (due to frequent
use of diuretics and digitalis).1,2 To make matters worse, many, Jawaharlal Nehru Medical
harashtra, India.
mar).
inical Gerontology & Geriatrics. Pub
d/4.0/).medications taken by the elderly and the stress they often endure
also tend to cause magnesium loss, further lowering tissue mag-
nesium levels.
Disorders of magnesium metabolism are among the most
common electrolyte disturbances in hospitalized patients, espe-
cially in the critically ill elderly, and are frequently unrecognized.
The prevalence of hypomagnesemia (measuring total serum mag-
nesium) has awide range (11e61%), and a considerable controversy
exists regarding its effects on morbidity and mortality.3e8 The
incidence of hypomagnesemia is reported to be 2% in the general
population, 10e20% in hospitalized patients, 50e60% in intensive
care unit (ICU) patients, 30e80% in persons with alcoholism, and
25% in outpatients with diabetes.2
No data are available from India as far as critical elderly in-
dividuals are concerned. In this study, we have tried to correlate
serum Mg levels with outcomes in elderly patients of the medicallished by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
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need for mechanical ventilatory support and its duration, and the
ultimate outcome (discharge/death).2. Methods
This prospective observational study was carried out in the
MICU of Acharya Binova Bhave Rural Hospital attached with
Jawahar Lal Nehru Medical College, Wardha, Maharashtra, in rural
central India, from March 2013 to October 2013, after approval by
the Institutional Ethics Committee. Among the 202 elderly patients
admitted to the MICU, 172 were included in this study. Patients
were enrolled at random, and the selection bias was avoided by
registering those patients who fulﬁlled the criteria for critical
illness on the basis of a severity scoring system (Acute Physiology
and Chronic Health Evaluation-II). Thirty patients, of whom 20
were stable and eight had ﬁnancial constraints, were excluded from
the study, as shown in the ﬂowchart in Figure 1. Patients who had
received magnesium prior to admission to the MICU (although
there were no such case) or long-term medication with proton
pump inhibitors (2 patients with a history of acid peptic disease)
were excluded. Demographic data (age and sex), past medical
history, medications administrated, and length of ICU stay were
recorded for each patient. Blood, urine, and endotracheal secretions
of every febrile patient were sent for culture screen. Blood samples
were collected for the estimation of serum total magnesium levels
on admission to the MICU, which was determined by a colorimetric
method. This study did not interfere with patient management in
theMICU. Study participants with hypomagnesemia did not receive
magnesium replacement in our research. The normal reference
value of serum total magnesium was between 1.5 mg/dL and
2.5 mg/dL.4 Patients with a magnesium level of < 1.5 mg/dL were
considered to have hypomagnesemia. Statistical analysis was per-
formed using descriptive and inferential statistics. All data were
expressed as mean± standard deviation. Analysis was performed
using the test statistics Student t test for the difference of means,Figure 1. Flowchart showing enrolment of patients. APACHE II¼ Acute PhChi-square test, and correlation. The software used in the analysis
included SPSS version 17.0 (SPSS Inc., Chicago, IL, USA) and Graph
pad Prism 5.0 (IBM Corporation, www.ibm.com/software/
analytics/spss/), and a p value of <0.05 was considered signiﬁcant.3. Results
A total of 172 elderly patients, aged 60 years and older (mean
age, 69.32± 7.32 years for male and 64.30± 4.11 years for female
patients), who were admitted to the MICU were enrolled in this
study. Baseline comparison of the characteristics of study patients
is shown in Table 1. On admission, 60/102 (58.82%) male elderly
patients and 42/102 (42.18%) female elderly patients had hypo-
magnesemia. The lowest serum magnesium value recorded was
1mg/dL, while the highest value was 2.5 mg/dL. Themean duration
of stay in the MICU was 5.61± 5.55 days in patients with a normal
magnesium level and 5.57± 6. 10 days in patients with hypomag-
nesemia, while the total duration of stay was 5.59± 5.87 days with
t¼ 0.39 and p¼ 0.5 (Table 2). Fifty-nine (57.84%) patients with
hypomagnesemia neededmechanical ventilatory support, while 43
(42.15%) patients did not require this support; the difference was
not statistically signiﬁcant (p¼ 0.18 and c2¼ 3.37). The mean
duration of ventilatory assistance for the hypomagnesemic group
was 3.07± 5.05 days and that for the normomagnesemic groupwas
2.15± 3.46 days; the difference was not statistically signiﬁcant
(p¼ 0.09 and t¼ 1.32; Table 2). The cure/discharge rates were 50
(71.42%) for patients with normal magnesium and 62 (60.78%) for
those with low magnesium, and the difference was not statistically
signiﬁcant. The mortality rate in the hypomagnesemic group was
39.21% (40), whereas that in the normomagnesemic group was
28.57% (20) (c2¼ 2.07, p¼ 0.15}. Finding of the association between
characteristics of study participants and hypomagnesemia is shown
in Table 2. The major groups of patients admitted to the MICU were
grouped as patients with cirrhosis, chronic kidney disease (CKD),
chronic obstructive pulmonary disease, diabetes mellitus, ischemic
heart disease, malaria, sepsis, stroke, and others (Table 2).ysiology and Chronic Health Evaluation-II; ICU¼ intensive care unit.
Table 1








Mean age (SD) 69.32 (7.32) 64.30 (4.11) 67.43 (6.77) p< 0.01
Blood pressure
Normal 94 (87.85) 57 (87.69) 151 (87.79) p¼ 0.5770
Hypertension 13 (12.14) 8 (12.30) 21 (12.20)
QT
Normal 78 (60.94) 50 (39.06) 128 (74.42) c2¼ 0.165
p¼ 0.6844Prolonged 29 (65.91) 15 (34.09) 44 (25.58)
Diagnosis
Cirrhosis 15 (14.01) 1 (01.53) 16 (9.30) Not applicable
CKD 7 (6.54) 5 (7.69) 12 (6.98)
IHD 12 (11.21) 9 (13.84) 21 (12.21)
COPD 3 (2.80) 1 (1.53) 4 (2.33)
DM 1 (00.90) 2 (3.07) 3 (1.74)
Malaria 9 (8.41) 9 (13.84) 18 (10.47)
Sepsis 21 (19.62) 21 (19.62) 42 (24.42)
Stroke 3 (2.80) 6 (9.23) 9 (5.23)
Other 36 (33.64) 11 (16.92) 47 (27.33)
Data are presented as n (%), unless otherwise indicated.
QT is electrocardigraphic changes.
CKD¼ chronic kidney disease; COPD¼ chronic obstructive pulmonary disease; DM¼ diabetes mellitus; IHD¼ ischemic heart disease; SD¼ standard deviation.
Table 2










Mean age (SD) 66.42 (6.75) 68.11 (6.73) 67.43 (6.77) t¼ 1.03
p¼ 0.30
Sex
Male 47 (67.14) 60 (58.82) 107 (62.21) c2¼ 1.22
p¼ 0.26Female 23 (32.85) 42 (42.17) 65 (37.79)
BP
Normal 61 (87.14) 90 (88.23) 151 (87.79) c2¼ 0.04
p¼ 0.83Hypertension 9 (12.85) 12 (11.76) 21 (12.21)
QT
Normal 56 (80) 72 (70.58) 61 (35.47) c2¼ 1.93
p¼ 0.16Prolonged 14 (20) 30 (29.41) 111 (64.53)
Diagnosis
Cirrhosis 4 (5.71) 12 (11.76) 16 (9.30) Not applicable
CKD 2 (8.33) 10 (9.80) 12 (6.98)
IHD 7 (9.52) 14 (13.72) 21 (12.21)
COPD 2 (2.85) 2 (1.9) 4 (2.33)
DM 2 (2.85) 1 (0) 3 (1.74)
Malaria 6 (7.14) 12 (11.76) 18 (10.47)
Sepsis 16 (22.85) 26 (25.49) 42 (24.42)
Stroke 5 (7.14) 4 (3.9) 9 (5.23)
Other 26 (37.14) 21 (20.58) 47 (27.33)
Hypokalemia 0 (0) 74 (72.54) 74(43.02)
Hyperkalemia 3 (4.28) 0 (0) 3(1.74)
Hypoalbuminemia 0 86 (84.31) 86(50)
Outcome
Discharged/cured 50 (71.42) 62 (60.78) 112 (65.12) c2¼ 2.07
p¼ 0.15Death 20 (28.57) 40 (39.21) 60 (34.88)
ICU stay (d)
Mean (SD) 5.61 (5.55) 5.57 (6.10) 5.59 (5.87) t¼ 0.39
p¼ 0.5
Requirement of ventilator support
Yes 32 (45.71) 59 (57.84) 91 (52.91) c2¼ 3.37
p¼ 0.18No 38 (54.28) 43 (42.15) 81 (47.09)
Duration of ventilator support (d)
Mean (SD) 2.15 (3.46) 3.07 (5.05) 2.70 (3.46) t¼ 1.32
p¼ 0.09
APACHE II 19.26± 4.37 21.82± 5.90 P¼ 0.24
Data are presented as n (%), unless otherwise indicated.
QT is electrocardigraphic changes.
APACHE II¼Acute Physiology and Chronic Health Evaluation-II; BP¼ blood pressure; CKD¼ chronic kidney disease; COPD¼ chronic obstructive pulmonary disease;
DM¼ diabetes mellitus; IHD¼ ischemic heart disease; SD¼ standard deviation.
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Table 3
Logistic regression for the correlation between hypomagnesemia and various patient characteristics.
Correlation variable Standard error Signiﬁcance OR 95% CI for OR
Lower bound Upper bound
Age 0.375 0.225 1.576 0.756 3.288
sex 0.361 0.171 0.610 0.300 1.238
BP 0.396 0.699 1.165 0.536 2.534
ECG QT prolongation 0.394 0.245 1.581 0.730 3.426
Requirement of ventilation 0.411 0.271 1.571 0.702 3.513
Duration of ventilation 0.643 0.424 1.672 0.474 5.898
MICU stay 0.488 0.258 0.576 0.221 1.498
Outcome 0.419 0.966 1.018 0.448 2.312
QT is electrocardigraphic changes.
BP¼ blood pressure; CI¼ conﬁdence interval; ECG¼ electrocardiogram; MICU¼medical intensive care unit; OR¼ odds ratio.
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mination of factors associated with hypomagnesemia. Unfortu-
nately, none of the variables had an independent association with
serum magnesium levels (Table 3).
4. Discussion
This study points to a possible impact of serum magnesium
levels on outcomes in critically ill elderly patients in whom aging
itself is a comorbidity. In our study, of the 172 critically ill elderly
patients admitted to the MICU, 102 (59.30%) were hypo-
magnesemic. This suggests frequent occurrence of lowMg in them.
In a study by El Said and Aly,9 23% of critically ill elderly patients
had a low Mg level and 59% of them had a normal Mg level. The
primary end points of this study were serum Mg levels and death/
discharge rates of critically ill elderly patients. Secondary outcome
measures were the associated chronic diseases and length of ICU
stay, as well as the need of ventilators.
The three major factors that affect magnesium requirements,
particularly in the elderly, are as follows: (1) dietary factors such as
poor intake, and intake of reﬁned processed food, excess ﬁber, and
excess sugar; (2) host factors such as anabolism or catabolism,
ischemia, chronic disease, decreased intestinal absorption, increased
renal excretion, hormonal, enzyme, vitamin imbalance, and alcohol
consumption; and (3) environmental factors such as medications
(cardiac medications, diuretics, antibiotics, and purgatives) and
stress (provoked and psychological diseases).9 We have not con-
ducted a detailed survey regarding the exact etiology of hypomag-
nesemia in our study patients, but it may be multifactorial.
There is no doubt that the proportion of macronutrients in the
diet can inﬂuence magnesium absorption and utilization. The
average diet of an elderly individual generally contains more car-
bohydrates, and less proteins and fats than his/her younger coun-
terpart.10 The “Western diet” is considered relatively deﬁcient in
magnesium, while the “Oriental diet” is traditionally characterized
by a greater intake of fruits and vegetables, and is therefore richer
in magnesium.10 In our country, somehow the diet is gradually
becoming westernized as the nation has become more afﬂuent.
However, no published data of this kind on rural India were avail-
able. Excess sugar is associated with magnesiuria, and excess ﬁber
can decrease gastrointestinal absorption of magnesium. Aging is
also associated with a high frequency of clinical situations associ-
ated with hypomagnesemia. Older patients, because of their pro-
clivity for cardiovascular disorders, are more likely to take digitalis
and diuretic preparations. Urinary magnesium excretion increases
by 25e400% following digitalis and diuretic therapy.11 Stress, dia-
betes, and gastrointestinal disorders, all common in the agedpeople, frequently have a role in magnesium depletion. Medica-
tions to treat infections (aminoglycosides) and constipation (pur-
gatives) can also lead to hypomagnesemia.11
Various studies have shown a varying relationship between
hypomagnesemia and mortality/morbidity rates. On average, a
higher mortality rate was detected in hypomagnesemia patients
irrespective of their age when compared with normomagnesemic
patients, as reported by Kumar et al4 (38.56% vs. 14.73% ), Limaye
et al5 (57% vs. 31%), Safavi and Honarmand7 (55% vs. 35%), and
Rubeiz et al8 (46% vs. 25%). This study in critical elderly patients
revealed the mortality rate in the hypomagnesemic group to be
39.21% (40), which was higher than the rate of 28.57% (20) in the
normomagnesemic group (c2¼ 2.07, p¼ 0.15).
Hypomagnesemia and sepsis have an important role in
increased mortality and morbidity, especially in the aged people.
Hypomagnesemia is associated with increased release of endo-
thelin and proinﬂammatory cytokines.12,13 This was strongly
associated with increased mortality in experimental sepsis, and
Mg replacement provided signiﬁcant protection against endo-
toxin challenge. This effect was due to the downregulation of the
release of inﬂammatory cytokines (tumor necrosis factor-alpha
and interleukin-6).14e16 Sepsis was an independent risk factor
for developing hypomagnesemia during ICU stay, as found by
Soliman et al.13 In the studies conducted by Kumar et al4 and
Limaye et al,5 the incidence of sepsis was twice as common in
hypomagnesemic patients than in normomagnesemic patients.
Hypomagnesemia is also associated with diabetes mellitus,
which may be due to increased renal losses of Mg that accom-
pany glycosuria, as seen in the studies by Kumar et al4 and
Limaye et al.5 Hypomagnesemia also leads to muscle weakness
and respiratory failure, causing difﬁculty in weaning the patient
from the ventilator. In a study by Kumar et al,4 it was observed
that patients with hypomagnesemia needed ventilatory support
more frequently and for a longer duration. However, no signiﬁ-
cant difference was found in the duration of ventilation between
the two groups (p¼ 0.18 and c2¼ 3.37). Fiaccadori et al17 had
observed that patients with low muscle Mg were on ventilatory
support for more number of days. Safavi and Honarmand7 had
found that in patients with hypomagnesemia, the duration of
mechanical ventilation was longer (7.2 days vs. 4.7 days,
p< 0.01). Prolonged ventilation is not just due to muscle weak-
ness causing difﬁculty in weaning. Hypermagnesemia is charac-
teristically associated with neuromuscular blockade and muscle
weakness, and therefore also with prolonged ventilation time.7
Hypermagnesemia were not observed in our patients; the
maximum level was 2.5 mg/dL. In the study carried out by
Soliman et al,13 there was no difference in the length of ICU stay
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However, patients who developed hypomagnesemia during their
ICU stay had a longer duration of stay in the ICU. In the study
conducted by Limaye et al,5 there was also no difference in the
length of ICU stay between hypomagnesemic and normo-
magnesemic patients. In a study by Kumar et al,4 there was a
signiﬁcant difference in the length of ICU stay between the
hypomagnesemic and normomagnesemic groups of patients
(5.46± 5.75 days vs. 3.93± 3.88 days, p¼ 0.0002). In this study,
the mean duration of stay in the MICU was 5.61 ± 5.55 days for
patients with a normal magnesium level and 5.57 ± 6.10 days for
patients with hypomagnesemia.
4.1. Limitations
The major ﬂaws of our design and possible biases were con-
founding factors. For example, electrolyte abnormalities such as
hypokalemia are frequently associated with magnesium deﬁciency
due to impairment of NaeKeATPase activity.18 As 30% of magne-
sium is bound to albumin and is therefore inactive, hypo-
albuminemic states as in cirrhosis may lead to spuriously low
magnesiumvalues. Sepsis and diabetes are independent risk factors
for developing hypomagnesemia.4,5,13 CKD patients possess a
higher chance of having a higher magnesium level. In moderate
CKD, increases in the fractional excretion of magnesium largely
compensate for the loss of glomerular ﬁltration rate to maintain
normal serum magnesium levels. However, in more advanced CKD
(as creatinine clearance falls below 30 mL/min), this compensatory
mechanism becomes inadequate such that overt hypermagnesemia
develops frequently in patients with creatinine clearances at
<10mL/min.19 It is a shortcoming of our design andwewere unable
to control these possible confounders adequately.
Another limitation is medication, which may be one of the
important reasons to result in hypomagnesemia. We have not
collected the medication information of our patients.
5. Conclusion
Mg alterations have frequently been observed in critically ill
elderly patients, as in this study, who have a high prevalence of
hypomagnesemia. Physicians should be alert to the high incidence
of hypomagnesemia in critically ill elderly patients and should
consider a routine monitoring program, as hypomagensemia may
be associated with adverse outcomes.Conﬂicts of interest
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